期刊文献+

E-cadherin和P120ctn在脊柱脊索瘤中的异常表达 被引量:1

Altered expression of E-cadherin/P120ctn complex in spinal chordoma
下载PDF
导出
摘要 目的探讨脊柱脊索瘤中E-cadherin和P120ctn的表达及其与肿瘤临床病理特征、肿瘤局部复发之间的关系。方法应用免疫组化方法检测40例脊柱脊索瘤标本和5例胎儿脊索组织标本中E-cadherin和P120ctn的表达情况。结果脊索瘤标本中E-cadherin和P120ctn的胞膜表达减低率分别为75.0%(30例)和67.5%(21例)。E-cad-herin的表达与肿瘤侵犯的椎节数目之间存在相关性(P<0.05),P120ctn的表达与肿瘤的病理学分级存在相关性(P<0.01)。二者均与肿瘤的平均复发时间之间存在相关性(P<0.05和P<0.01)。另外,E-cadherin和P120ctn的表达下调之间存在相关性(P<0.05)。COX回归模型分析证实P120ctn和肿瘤病理分级是脊柱脊索瘤术后局部复发的独立预测因素。结论脊柱脊索瘤中常发生E-cadherin和P120ctn的胞膜表达下调,且与脊柱脊索瘤的发生、发展有关。二者均是肿瘤侵袭和局部复发的有价值的生物学预测指标,P120ctn是脊柱脊索瘤局部复发的独立预测因素。 Objective To investigate the expression of E-cadherin and P120ctn in spinal chordomas and its correlation with the clinicopathologic parameters and Local recuiTence of this tumor. Methods The immunohistochemical study was performed to detect the expression of E-cadherin and P120ctn in 40 spinal chrodomas specimens and 5 fetal notochord. Results In the chordoma speciments, the expression of E-cadherin and P120ctn was reduced in 30 speciments (75.0%) and 27 speciments(67.5% ) , respectively. The expression of E-cadherin was significantly correlated with the amount of affected columns ( P 〈 0.05 ), and the expression of P120etn was significantly correlated with pathologic grade of this tumor ( P 〈 O. Ol ). Their expession was both significantly con'elated with local tumor recurrence (P 〈 0.05 and P 〈 O. 01 ). In addition, there was significant correlation between the altered expression of E-cadherin and P120ctn (P = 0.035). It was found that P120ctn and the pathologic grade were the independent prognostic factors of tumor local recurrence by a Cox regression model. Conclusion Down regulation of E-cadherin and P120ctn expression occurs frequently in spinal chordomas, which may be associated with the morbidity and progression of spinal chordomas. Both of them may be valuable biologic markers for predicting tumor invasion and local recurrence, but only P120ctn is an independent prognostic factor for local recurrence of spinal chordomas.
出处 《脊柱外科杂志》 2009年第4期193-197,共5页 Journal of Spinal Surgery
关键词 脊索瘤 钙粘着糖蛋白类 染色与标记 P120CTN Chordoma Cadherins Staining and labeling P120ctn
  • 相关文献

参考文献15

  • 1袁峰,杨惠林,张志明,包肇华,唐天驷.骶骨脊索瘤的靶血管栓塞和手术治疗[J].脊柱外科杂志,2003,1(2):89-91. 被引量:6
  • 2Boriani S,Bandiera S,Biagini R,et al.Chordoma of the mobile spine:fifty years of experience[J].Spine (Phila Pa 1976),2006,31(4):493-503.
  • 3Frankel HL,Hancock DO,Hyslop G,et al.The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia.I[J].Paraplegia,1969,7(3):179-192.
  • 4Karnofsky DA.The use of nitrogen mustards in the palliative treatment of carcinoma[J].Cancer,1948,1:634-656.
  • 5Naka T,Fukuda T,Chuman H,et al.Proliferative activities in conventional chordoma:a clinicopathologic,DNA flow cytometric,and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia[J].Hum Pathol,1996,27(4):381-388.
  • 6Gamallo C,Palacios J,Suarez A,et al.Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma[J].Am J Pathol,1993,142(4):987-993.
  • 7Kuroiwa K,Konomoto T,Kumazawa J,et al.Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin,alpha-,beta-,and gamma-catenin,and p120) in sarcomatoid renal cell carcinoma[J].J Surg Oncol,2001,77(2):123-131.
  • 8Naka T,Oda Y,Iwamoto Y,et al.Immunohistochemical analysis of E-cadherin,alpha-catenin,beta-catenin,gamma-catenin,and neural cell adhesion molecule (NCAM) in chordoma[J].J Clin Pathol,2001,54(12):945-950.
  • 9Horiguchi H,Sano T,Qian ZR,et al.Expression of cell adhesion molecules in chordomas:an immunohistochemical study of 16 cases[J].Acta Neuropathol,2004,107(2):91-96.
  • 10Triana A,Sen C,Wolfe D,et al.Cadherins and catenins in clival chordomas:correlation of expression with tumor aggressiveness[J].Am J Surg Pathol,2005,29(11):1422-1434.

二级参考文献11

  • 1徐万鹏,宋献文,乐守玉,蔡 伯,吴捷.骶骨肿瘤及其外科治疗(123例手术分析)[J].中华骨科杂志,1994,14(2):67-71. 被引量:74
  • 2[1]York JE ,Kaczaraj A, Abi-Said D,et al. Sacral chordoma: 40-year experience at major cancer center[J]. Neurosurgery, 1999,44:74-79
  • 3[2]Tsukasa Y, Shin-ichiro T, Toshinao T,et al. The surgical management of sacrococcygeal chordoma[J]. Cancer, 1999, 85:878-883
  • 4[4]Simpson AH, Porter A, Davis A. Cephalad sacral resection with a combined extended ilioinguinal and posterior approach[J]. JBJS(Am ),1995,77(3):405-411
  • 5[7]Gellad FE, Sadato N, Numaguchi Y,et al. Vascular metastatic lesions of the spine: preoperative embolization[J]. Radiology, 1990,176:683-686
  • 6[9]Samson IR, Springfield DS, Suit HD. Operative treatment of sacrococcygeal chordoma[J].JBJS (Am), 1993, 75:1476-1481
  • 7[10]Chandawarkar RY. Sacrococcygeal chordoma: review of 50 consecutive patients[J]. World J. Surg, 1996, 20:717-719
  • 8[11]Wuisman P, Lieshout O, Sugihara S,et al. Total sacrectomy and reconstruction: oncologic and functional outcome[J]. Clinical orthopaedics and related research. 2000,381:192-203
  • 9[12]Tomita K, Tsuchiya H. Total sacrectomy and reconstrution for huge sacral tumors[J]. Spine, 1990,15:1223-1227
  • 10杨惠林,倪才方,唐天驷,洪天禄,许立,杨同其,徐耀增,包肇华,刘一之.靶血管栓塞后手术治疗骶骨肿瘤[J].中华骨科杂志,1998,18(11):646-648. 被引量:47

共引文献5

同被引文献17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部